Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2006 10:52 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan's Alzheimer's Drug Candidate Caprospinol Shows Favorable Results in Acute Toxicity Study

LAS VEGAS, Aug. 29, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's research compound Caprospinol (SP-233) demonstrated...
August 23, 2006 11:14 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Strengthens Business Development Capability

LAS VEGAS, Aug. 23, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it is strengthening its business development capability with...
August 08, 2006 10:34 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals Inc. Purchases Back Canadian Rights for HIV Drug from Quest PharmaTech

LAS VEGAS, Aug. 8, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has purchased back the Canadian licensing rights related to...
July 27, 2006 10:06 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Plans to Acquire Metastatin Pharmaceuticals to Buy Rights to Novel Cancer Drug

LAS VEGAS, July 27, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that Samaritan has signed a letter of intent ("LOI") whereby...
July 11, 2006 09:51 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Reports Its Alzheimer's Drug Caprospinol Cleans the Brain of Plaque in Preclinical Animal Study

LAS VEGAS, July 11, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's drug SP-233 (Caprospinol), not only stops amyloid...
June 26, 2006 09:37 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Builds Up Patent Portfolio: Samaritan Announces U.S. Patent Issued for Peripheral-Type Benzodiazepine Receptor Associated Proteins

LAS VEGAS, June 26, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it is continuing to expand its broad worldwide patent portfolio in...
June 20, 2006 10:52 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Receives a Notice of Claim Allowance in its European Patent for New Type of Plaque Clearing Cardiovascular Drug SP-1000

LAS VEGAS, June 20, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it has received a notice of allowance of claims for European patent...